Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
Abhilasha Pharma Private Limited, is an unlisted private company incorporated on 29 December, 2005. It is classified as a private limited company and is located in , Gujarat. It's authorized share capital is INR 50.00 lac and the total paid-up capital is INR 50.00 lac.
Abhilasha Pharma's operating revenue range is INR 1 cr - 100 cr for the financial year ending on 31 March, 2023. It's EBITDA has increased by 1.01% over the previous year. At the same time, it's book networth has increased by 12.79%.
Read more
** All rupee values in INR crores.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
** Delivery timelines are on best-effort basis during working hours. Filings 3-4 hours. Reports 24-48 hours.
* INR 349 for 20+ credits purchase
1 credit = one company dashboard
| State | Type | Address |
|---|
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Amrut Nathalal Chaudhari
Shareholder
|
01878776 | 20 years |
| Director | Mukeshkumar Dhirajlal Soni
Shareholder
|
01920337 | 19 years |
| Director | Priyang Yashvantbhai Chaudhari
Shareholder
|
01985869 | 20 years |
| Director | Hiren Amrutlal Chaudhari
Shareholder
|
02100477 | 20 years |
| Director | Bhargavkumar Mukeshbhai Soni
Shareholder
|
02107159 | 20 years |
| Director | Yashvantbhai Joitaram Chaudhari
Shareholder
|
02085841 | 7 years |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
HDFC Bank Limited
No. of Loans: 2
Total Amount : 26.0 cr
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| ATHARVA E-GEN PRIVATE LIMITED |
Active
|
1.0 L | 2 | Gujarat |
| ABHELFEN LIFE SCIENCE PRIVATE LIMITED |
Active
|
50.0 L | 2 | Gujarat |
| AMBICA PHARMACHEM PRIVATE LIMITED |
Active
|
52.7 L | 2 | |
| ALMA LIFE SCIENCE PRIVATE LIMITED |
Active
|
50.0 L | 1 | Gujarat |
| AUKEA LIFE SCIENCES PRIVATE LIMITED |
Active
|
49,500.0 | 2 | Gujarat |
| RANGODADHI CHEMICALS PRIVATE LIMITED |
Active
|
18.0 L | 2 | Gujarat |
Read more
The incorporation date of ABHILASHA PHARMA PRIVATE LIMITED is 29 December, 2005
The authorized share capital of ABHILASHA PHARMA PRIVATE LIMITED is INR ₹ 50.0 L.
The paid-up capital of ABHILASHA PHARMA PRIVATE LIMITED is INR ₹ 50.0 L.
The registered address of ABHILASHA PHARMA PRIVATE LIMITED is 11, CHAUDHARI CO. OP. SOCIETYLIMITED, PALDI GAM NR.NARHARI BHUVAN, PALDI, AHMEDABAD 380, 0, AHMEDABAD, Gujarat, India, 380007 - 380007
The CIN number of ABHILASHA PHARMA PRIVATE LIMITED is U24230GJ2005PTC047400.